Clinical Trial Update: Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial from Shandong Cancer Hospital and Institute is evaluating adapted guided stereotactic body radiotherapy with chemotherapy and the novel antibo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING